Status: current, Defined. Date: 31-Jul 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2571351000168113 | cyproterone acetate 2 mg + ethinyloestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 480493011000036117 | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 480494011000036115 | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21 tablets] (&) inert substance tablet [7 tablets], 28 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | has MPUU | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet | true | Inferred relationship | Some | 1 | |
| cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | has MPUU | inert substance tablet | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Juliet-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Estelle-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Jene-35 ED (cyproterone acetate 2 mg + ethinylestradiol 35 microgram) tablet [21 tablets] (&) (inert substance) tablet [7 tablets], 28 tablets (trade product pack) | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Juliet-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Estelle-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Carolyn-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Carolyn-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Diane-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Diane-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Brenda-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Brenda-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Laila-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Laila-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Chelsea-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Jene-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Katie-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
| Katie-35 ED (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Dermapil (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 28 | Is a | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | |
| Dermapil (21 x 2 mg/35 microgram tablets, 7 x inert tablets), 3 x 28 | has subpack | True | cyproterone acetate 2 mg + ethinylestradiol 35 microgram tablet [21] (&) inert substance tablet [7], 28 | Inferred relationship | Some | 1 |
Reference Sets
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR